ArticleImmunologic research2026
Single-cell RNA sequencing reveals the interaction of TREM2
Article in Immunologic research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Scalp psoriasis exhibits unique clinical features and relative resistance to conventional therapies compared with lesions on other body sites. However, the immune landscape underlying these characteristics preferentially observed in scalp lesions remains poorly understood. To characterize immune-cell heterogeneity and site-associated intercellular interactions in scalp psoriasis, with a focus on inflammatory T-cell and myeloid-cell programs that may contribute to persistent local inflammation. We performed single-cell RNA sequencing on CD45⁺ immune cells isolated from scalp and body plaque lesions of patients with psoriasis, along with healthy controls. A total of 41,438 immune cells were subjected to downstream analyses including clustering, gene set enrichment, pseudotime trajectory inference, and CellChat-based intercellular interaction modeling. Spatial co-localization was validated using multiplex immunofluorescence. Scalp lesions showed a marked enrichment of IL-17⁺ CD8⁺ tissue-resident memory T (Tc17) cells, characterized by co-expression of IFNG and the lipid transporter FATP2 (SLC27A2). Pseudotime analysis revealed a transition from IL7R⁺ tissue-resident memory T cells to Tc17 cells, preferentially occurring in the scalp. TREM2⁺ macrophages in scalp lesions displayed elevated inflammatory and antigen-presentation signatures, including increased MHC-I expression. CellChat identified strengthened MHC-I-mediated interactions between TREM2⁺ macrophages and Tc17 cells in the scalp, which were corroborated by immunofluorescence demonstrating co-localization of FATP2⁺ Tc17 and TREM2⁺ macrophages around sebaceous units. This study identifies a scalp-enriched immune interaction involving TREM2⁺ macrophages and FATP2⁺ Tc17 cells, which may contribute to the persistence and localized nature of inflammation in scalp psoriasis.Trial registration: Not applicable.
Indexed as
Identifiers
42806169What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.